CAT and acute myeloid leukemia: On the basis of the IPSS-R prognostic stratification, we observed that MDS patients with a high risk of progression to AML presented higher values of GPx activity (p < 0.05) (Figure 5A) with a significant decrease in CAT activity (p < 0.05) compared to low-risk MDS categories.